Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature

Diagnostic Pathology

Fazil Tuncay Aki²  Berrin Buyukeren¹  Julia A. Bridge⁴  Oguz Aydin³  Kemal Kosemehmetoglu¹  Dilek Ertoy Baydar¹ 

[1] Department of Pathology, Hacettepe University Hospital, Ankara, Turkey;Department of Urology, Hacettepe University Hospital, Ankara, Turkey;Department of Pathology, Ondokuz Mayis University Hospital, Samsun, Turkey;Departments of Pathology/Microbiology, Pediatrics and Orthopaedic Surgery, Nebraska Medical Center, Omaha, NE, USA

关键词: Translocation;    CREB3L1;    EWSR1;    Kidney;    Sclerosing epithelioid fibrosarcoma;   

Others  :  1230710
DOI  :  10.1186/s13000-015-0420-z

 received in 2015-08-01, accepted in 2015-10-01,  发布年份 2015

【 摘 要 】

The authors present two cases of primary sclerosing epithelioid fibrosarcoma (SEF) of the kidney. Both patients had a mass in the upper part of the left kidney without any primary extrarenal neoplastic lesions. Grossly, the tumors were solid masses both measuring 7.5 cm in the greatest diameter. Histologically, one of the lesions exhibited a predominantly lobular growth of round or oval small uniform epithelioid cells in variable cellularity. Circular zones of crowded tumor cells alternating with hypocellular collagenous tissue in a concentric fashion around entrapped native renal tubules were distinctive. The second case was distinctive with significant cytological atypia in the neoplastic cells and prominent reactive proliferations in the trapped renal tubules. Immunohistochemically, vimentin, bcl-2 and MUC4 were diffusely positive in both. They were negative for S-100 protein, CD34, and desmin, whereas CD99 were positive in one lesion. Fluorescence in situ hybridization assay using dual staining probes detected EWSR1-CREB3L1 fusion in each lesion, which is characteristic molecular findings of SEF. One patient presented widespread distant metastases at the time of diagnosis. In the other, no tumor deposits were detected other than primary. Both patients have been alive with 30 and 10 month follow-ups, respectively. These tumors are 6th and 7th cases of primary renal SEF in the literature confirmed by FISH study, which exhibit unique and remarkable histomorphologic features.

【 授权许可】

   
2015 Ertoy Baydar et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

Fig. 9.

Fig. 10.

Fig. 11.

Fig. 12.

Fig. 13.

【 参考文献 】

• [1]Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP et al.. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am J Surg Pathol. 2014; 38(6):801-8.
• [2]Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ et al.. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol. 2012; 36(10):1444-51.
• [3]Prieto-Granada C, Zhang L, Chen HW, Sung YS, Agaram NP, Jungbluth AA et al.. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: A pathologic and molecular study of 18 cases. Genes Chromosomes Cancer. 2014.
• [4]Antonescu CR, Rosenblum MK, Pereira P, Nascimento AG, Woodruff JM. Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol. 2001; 25(6):699-709.
• [5]Chow LT, Lui YH, Kumta SM, Allen PW. Primary sclerosing epithelioid fibrosarcoma of the sacrum: a case report and review of the literature. J Clin Pathol. 2004; 57(1):90-4.
• [6]Meis-Kindblom JM, Kindblom LG, Enzinger FM. Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol. 1995; 19(9):979-93.
• [7]Ossendorf C, Studer GM, Bode B, Fuchs B. Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review. Clin Orthop Relat Res. 2008; 466(6):1485-91.
• [8]Argani P, Lewin JR, Edmonds P, Netto GJ, Prieto-Granada C, Zhang L et al.. Primary Renal Sclerosing Epithelioid Fibrosarcoma: Report of 2 Cases With EWSR1-CREB3L1 Gene Fusion. Am J Surg Pathol. 2014.
• [9]Ohlmann CH, Brecht IB, Junker K, van der Zee JA, Nistor A, Bohle RM et al.. Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location. Ann Diagn Pathol. 2015.
• [10]Bai S, Jhala N, Adsay NV, Wei S. Sclerosing epithelioid fibrosarcoma of the pancreas. Ann Diagn Pathol. 2013; 17(2):214-6.
• [11]Frattini JC, Sosa JA, Carmack S, Robert ME. Sclerosing epithelioid fibrosarcoma of the cecum: a radiation-associated tumor in a previously unreported site. Arch Pathol Lab Med. 2007; 131(12):1825-8.
• [12]Tomimaru Y, Nagano H, Marubashi S, Kobayashi S, Eguchi H, Takeda Y et al.. Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cava. World J Gastroenterol. 2009; 15(33):4204-8.
• [13]Wojcik JB, Bellizzi AM, Dal Cin P, Bredella MA, Fletcher CD, Hornicek FJ et al.. Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series. Am J Surg Pathol. 2014; 38(11):1538-44.
• [14]Watanabe K, Suzuki T. Epithelioid fibrosarcoma of the ovary. Virchows Arch. 2004; 445(4):410-3.
• [15]Goldblum JR, Folpe AL, Weiss SW. Borderline and Malignant Fibroblastic/Myofibroblastic Tumors. In: Enzinger and Weiss's soft tissue tumors. 6th ed. Goldblum JR, Folpe AL, Weiss SW, editors. Saunders/Elsevier, Philadelphia, PA; 2014: p.288-340.
• [16]Doyle LA, Moller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2011; 35(5):733-41.
• [17]Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchere-Vince D, Collin F et al.. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol. 2007; 31(9):1387-402.
• [18]Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK. EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2013; 37(5):734-8.
• [19]Alevizopoulos A, Mygdalis V, Tyritzis S, Stravodimos K, Constantinides CA. Low-grade fibromyxoid sarcoma of the renal pelvis: first report. Case Rep Nephrol Urol. 2012; 2(2):87-91.
• [20]Arancio M, Ranzoni S, Delsignore A, Maffei N, Landi G, Mina A et al.. Fibromyxoid sarcoma of the kidney. A case report. Urologia. 2010; 77(4):263-6.
• [21]del Valle GN, Santos Largo J, Martinez-Sagarra Oceja J, Rodriguez TV. Fibromyxoid sarcoma of kidney. Actas Urol Esp. 2009; 33(9):1036-9.
• [22]Rubinstein JC, Visa A, Zhang L, Antonescu CR, Christison-Lagay ER, Morotti R. Primary Low-Grade Fibromyxoid Sarcoma of the Kidney in a Child with the Alternative EWSR1-CREB3L1 Gene Fusion. Pediatr Dev Pathol. 2014; 17(4):321-6.
• [23]Silverman JF, Nathan G, Olson PR, Prichard J, Cohen JK. Fine-needle aspiration cytology of low-grade fibromyxoid sarcoma of the renal capsule (capsuloma). Diagn Cytopathol. 2000; 23(4):279-83.
• [24]Suzuki T, Hiragata S, Hosaka K, Oyama T, Kuroda N, Hes O et al.. Malignant mixed epithelial and stromal tumor of the kidney: report of the first male case. Int J Urol. 2013; 20(4):448-50.